Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers

NCT00189540 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Arterial Occlusive Disease
Peripheral Vascular Disease
Ischemia
Ulcers

Interventions

GENETIC: HGF plasmid
GENETIC: Placebo

Sponsor

AnGes USA, Inc.